SCHEMBL8947334

SCHEMBL8947334

Cc1ccc(-c2nnnn2CC(=O)O)cc1[N+](=O)[O-]

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.56
HPGD P15428 1/20 0.56
GRK6 P43250 1/20 0.47
TSHR P16473 2/20 0.46
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
RAB9A P51151 2/20 0.40
MAPT P10636 6/20 0.40
LMNA P02545 4/20 0.40
NPC1 O15118 1/20 0.40
MAPK1 P28482 1/20 0.40
CYP3A4 P08684 1/20 0.39
RECQL P46063 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MITF O75030 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8947113 0.88 ALDH1A1 (0.54) ALDH1A1HPGDCYP1A2MEN1KMT2A
SCHEMBL8947269 0.87 TRPV1 (0.43) ALDH1A1HPGDGRK6TSHRCYP1A2
SCHEMBL8947333 0.84 ALDH1A1 (0.65) ALDH1A1HPGDTSHRCYP1A2POLB
SCHEMBL8947170 0.82 ALDH1A1 (0.66) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL8947307 0.80 ALDH1A1 (0.53) ALDH1A1HPGDMEN1KMT2ASMN1; SMN2
SCHEMBL8947331 0.79 ALDH1A1 (0.84) ALDH1A1HPGDPOLBLMNAHTT
SCHEMBL8947241 0.77 LMNA (0.46) ALDH1A1HPGDMEN1KMT2AMAPT
SCHEMBL5966727 0.77 ALDH1A1 (0.75) ALDH1A1HPGDPOLBRAB9AMAPT
SCHEMBL8947275 0.76 ALDH1A1 (0.61) ALDH1A1HPGDCYP1A2POLBMEN1
SCHEMBL8947235 0.74 ALDH1A1 (0.59) ALDH1A1HPGDPOLBMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE35281-E ANTIDIABETIC AGENTS WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-06-18 US disclosed
EP-0388967-B1 Aldose reductase inhibitor WAKAMOTO PHARMA CO LTD (JP) 1995-06-28 EP disclosed
US-5055481-A Alleviate diabetic complications WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-10-08 US disclosed
EP-0388967-A1 Aldose reductase inhibitor Wakamoto Pharmaceutical Co., Ltd. (JP) 1990-09-26 EP disclosed